Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

114.82
BATS BZX Real-Time Price
As of 12:37pm ET
 -2.48 / -2.11%
Today’s Change
95.80
Today|||52-Week Range
160.00
+5.31%
Year-to-Date
9 Stocks Trading Below the Peter Lynch Value
Jan 11 / GuruFocus News - Paid Partner Content
Here's Why Jazz Pharmaceuticals PLC Fell Out of Tune and Lost 22% in 2016
Jan 05 / MotleyFool.com - Paid Partner Content
Start the New Year off Right with 3 Best Biotech Stocks
Jan 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close117.30
Today’s open115.68
Day’s range113.97 - 115.99
Volume13,027
Average volume (3 months)621,640
Market cap$7.0B
Dividend yield--
Data as of 12:37pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+5.27%
Earnings growth (next 5 years)+13.55%
Revenue growth (last year)+12.95%
P/E ratio20.0
Price/Sales6.69
Price/Book4.50

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.12+0.28%
UTHRUnited Therapeutics ...-2.02-1.34%
IONSIonis Pharmaceutical...-1.66-3.45%
TSROTESARO Inc-1.65-1.05%
Data as of 12:37pm ET, 01/17/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$2.65
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs